A randomized, double blinded, dose ranging, placebo-controlled, phase 2b study to evaluate the efficacy and safety of PLN-74809 (bexategrast) for the treatment of idiopathic pulmonary fibrosis (IPF)
A randomized, double-blinded, placebo-controlled, phase 3 study of the efficacy and safety of inhaled Treprostinil in subjects with idiopathic pulmonary fibrosis
An Open-label Extension Study of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis
A randomized, double-blinded, placebo-controlled, multinational, phase 3 study of the efficacy and safety of inhaled Treprostinil in subjects with progressive pulmonary fibrosis
A Phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of ralinepag when added to pulmonary arterial hypertension(PAH) standard of care or PAH-specific background oral therapy in subjects with World Health Organization(WHO) Group 1 pulmonary hypertension(ADVANCE Outcomes)
A Study Evaluating the Long-term Efficacy and Safety of Ralinepag in Subjects with PAH via an Open-label Extension (ADVANCE- Extension)